Insulin Delivery Devices Market: Growth, Size, Share, and Trends
Insulin Delivery Device Market by Type (Insulin Pens (Reusable, Disposable), Insulin Pumps (Tethered, Tubeless), Insulin Pen Needle (Standard, Safety), Insulin Syringes, Others), Disease Type (Type 1 Diabetes, Type 2 Diabetes) - Global Forecast to 2030
USD 52.65 BN
MARKET SIZE, 2030
CAGR 8.3%
(2025-2030)
379
REPORT PAGES
454
MARKET TABLES
OVERVIEW
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The global insulin delivery devices market is projected to reach USD 52.65 billion by 2030 from USD 35.27 billion in 2025, at a CAGR of 8.3% during the forecast period. Insulin delivery devices are medical devices designed to administer insulin, a hormone used in the management of diabetes, into the body. These devices are primarily used by individuals with diabetes who require insulin therapy to regulate their blood sugar levels. Insulin pens, pumps, pen needles, and syringes are the most widely used delivery devices. The insulin delivery devices market is experiencing steady growth, primarily due to the increasing number of individuals diagnosed with diabetes. The rising prevalence of type 1 diabetes, in particular, is driving the demand for insulin delivery devices, as patients with this condition rely on insulin to manage their blood glucose levels.
KEY TAKEAWAYS
-
BY TYPEThe insulin delivery devices market can be categorized into several types: insulin pens, insulin pumps, insulin syringes, insulin pen needles, and other insulin delivery devices. Within the category of insulin pens, there are two main types: reusable insulin pens and disposable insulin pens. As of 2024, reusable insulin pens held the largest market share. Reusable insulin pens feature a delivery chamber designed to hold prefilled insulin cartridges. These devices are more cost-effective than disposable insulin pens, leading to their increasing popularity for insulin delivery. They provide significant advantages in terms of affordability, sustainability, and user-friendliness. Additionally, reusable pens offer environmental benefits.
-
BY DISEASE TYPEThe insulin delivery devices market is categorized into two segments based on disease type: type 1 diabetes and type 2 diabetes. In 2024, the type 2 diabetes segment held the largest market share. This growth is attributed to the increasing prevalence and incidence of type 2 diabetes worldwide. For instance, as per International Diabetes Federation, By 2050, their projection show that 1 in 8 adults, approximately 853 million, will be living with diabetes, an increase of 46%.
-
BY END USERThe wearable healthcare devices market is segmented into general health & fitness, remote patient monitoring, and home healthcare. General health & fitness wearables lead in demand due to their widespread use for preventive health, wellness tracking, and lifestyle management, followed by remote patient monitoring and home healthcare, which are increasingly adopted for chronic disease management and telehealth applications.
-
BY REGIONThe insulin delivery devices market is segmented by region into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Among these regions, Asia Pacific is anticipated to be the fastest-growing market with the CAGR of 8.5% for insulin delivery devices during the forecast period. This growth is primarily attributed to the rapidly increasing prevalence of diabetes, particularly in densely populated countries like India and China.
-
COMPETITIVE LANDSCAPEThe major market players have adopted both organic and inorganic strategies, including product launches, partnerships, and acquisitions. Leading companies such as Embecta Corp. (US), Novo Nordisk A/S (Denmark), Sanofi (France), Medtronic (Ireland), Eli Lily and Company (US) have strengthened their product portfolios and expanded their global presence to meet the rising demand for insulin delivery devices. Continuous innovation in insulin delivery devices, and advancement in syringe and needle technology has helped these players maintain competitive advantage in a rapidly evolving market
The insulin delivery devices market is experiencing consistent growth due to several factors. As the global population ages, the prevalence of conditions like diabetes is rising, leading to an increased demand for advanced insulin delivery devices. Additionally, government support and favorable reimbursement schemes are further promoting market growth.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The insulin delivery devices market is undergoing transformation as rising diabetes prevalence and technological innovation reshape customer strategies. Advanced insulin pens, pumps, and connected devices are improving dosing accuracy, ease of use, and patient adherence, creating strong demand among both hospitals and homecare settings. Favorable government initiatives and reimbursement policies in developed markets are accelerating adoption, while growing healthcare expenditure in emerging economies opens new opportunities. However, high device costs, limited reimbursement in certain regions, and needle-related anxiety continue to challenge uptake. These dynamics are pushing manufacturers and providers to balance innovation with affordability, patient comfort, and accessibility to sustain competitive advantage.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Drivers
Impact
Level
Level
-
Growing prevalence of diabetic population
-
Technological advancements in insulin delivery devices
RESTRAINTS
Impact
Level
Level
-
High cost and lack of reimbursement in developing countries
-
Needle anxiety in patients to affect the growth of the pen needles and syringes market
OPPORTUNITIES
Impact
Level
Level
-
Increasing research and development activities and strategic partnerships
-
Increasing healthcare expenditure on diabetes care
CHALLENGES
Impact
Level
Level
-
Needlestick injuries and misuse of injection pens
-
Lack of interoperability among insulin delivery devices
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver: Growing prevalence of diabetic population
The increasing prevalence of diabetes worldwide is significantly driving the growth of the insulin delivery devices market. According to the International Diabetes Federation (IDF) Atlas 2025, approximately 588.7 million people globally were affected by diabetes in 2024, and this number is projected to rise to 852.5 million by 2050, reflecting a 45% increase. The highest growth rate is expected in Africa at 142%, followed by the Middle East and North Africa at 92%, Southeast Asia at 73%, and South and Central America at 45%. As the incidence of diabetes continues to rise, governments and healthcare professionals are adopting advanced insulin delivery devices to enhance disease management and improve patient outcomes, thereby propelling the market on a global scale.
Restraint: Needle anxiety in patients
Needle anxiety is a significant barrier to the use of injectable insulin delivery devices. This issue affects not only new users and children but also adult patients. According to Harvard Health, an estimated 25% of adults have a fear of needles. Studies indicate that between one-fifth to one-third of people with diabetes are hesitant or unwilling to administer insulin injections for various reasons, including needle anxiety. Moreover, needlestick injuries present a safety concern for healthcare professionals and anyone else administering injections. The US National Institute for Occupational Safety and Health estimates that around 600,000 to 800,000 needlestick injuries occur in the US each year, which can lead to serious infections such as HIV and Hepatitis. The National Library of Medicine reports that the prevalence of fear of injections among individuals treated with insulin ranges from 6% to 43%. Those with needle phobia may experience severe anxiety, leading to panic attacks and avoidance of pen needles altogether.
Opportunity: Increasing healthcare expenditure on diabetes care
The global healthcare expenditure related to diabetes has significantly increased in recent decades. According to the IDF Diabetes Atlas 2025, total global health spending associated with diabetes reached USD 1.015 trillion in 2024, reflecting a remarkable 338% increase over the past 17 years. On average, USD 1,760 is spent per person on diabetes care.
Challenge: Needlestick injuries and misuse of injection pens
The global healthcare expenditure related to diabetes has significantly increased in recent decades. According to the IDF Diabetes Atlas 2025, total global health spending associated with diabetes reached USD 1.015 trillion in 2024, reflecting a remarkable 338% increase over the past 17 years. On average, USD 1,760 is spent per person on diabetes care. There are stark regional disparities in this expenditure. North America and the Caribbean have the highest diabetes-related health expenditure per adult, amounting to USD 7,812, followed by Europe at USD 2,951, South and Central America at USD 2,417, and the Western Pacific at USD 1,174. Furthermore, the differences at the country level are even more pronounced. In 2024, Switzerland reported the highest annual per-person expenditure on diabetes care at USD 12,234, followed by the US at USD 10,497 and Norway at USD 10,226.
Insulin Delivery Devices Market: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Focuses on manufacturing insulin delivery systems such as insulin syringes, pen needles, and injection devices designed for safe and reliable insulin administration. | Ensures consistent and accurate insulin dosing, enhances patient safety, and simplifies self-administration for diabetic patients. |
 |
Offers a wide range of advanced insulin pens, smart insulin pens, and prefilled delivery systems integrating connectivity features for diabetes management. | Promotes convenient and precise dosing, improves treatment adherence, and enables digital tracking for personalized diabetes care. |
 |
Develops insulin pumps, continuous glucose monitoring (CGM) systems, and hybrid closed-loop insulin delivery solutions integrating automated insulin adjustment. | Enhances glycemic control, reduces hypoglycemia risk, and minimizes manual intervention through automated insulin delivery. |
 |
Provides prefilled insulin pens, smart delivery platforms, and digital monitoring tools integrated with insulin formulations like Lantus® and Toujeo®. | Improves user comfort, ensures accurate dose delivery, and supports comprehensive diabetes management through connected solutions. |
 |
Offers reusable and disposable insulin pens and collaborates on digital insulin delivery platforms and smart pen technologies. | Simplifies daily insulin administration, improves dose precision, and supports patient adherence through intuitive and connected devices. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The ecosystem market map of the Insulin delivery devices market includes products used in hospitals, senior care facilities, rehabilitation facilities, home, and end users. Manufacturers of various Insulin delivery devices include organizations that heavily invest in research and development. Distributors include third parties and e-commerce sites linked with the organization to market Insulin delivery devices products. Research and product development include in-house research facilities, contract research organizations, and contract development and manufacturing organizations that play a key role in outsourcing services for product development to manufacturers. End users adopt Insulin delivery devices products during various stages of application. These end customers are the key stakeholders in the supply chain of the Insulin delivery devices market.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Insulin Deliver Devices Market, By Type
Based on type, the Insulin delivery devices market is divided into insulin pens, insulin pumps, insulin pen needles, insulin syringes, and other insulin delivery devices. Among these the insulin pen segment holds the largest markets share in 2024 across insulin delivery device market. The insulin pen segment holds the major share in the insulin delivery device market by type primarily due to its ease of use, convenience, and accuracy in dosing, which significantly enhances patient compliance
Insulin Deliver Devices Market, By Disease Type
Based on disease type, the insulin deliery devie market is divied int type 1 diabets & type 2 diabetes. Among these, in 2024 the type diabtes accounted for th mjor share owing toincrasing prevalence of type 2 diabetes. The increasing prevalence of Type 2 diabetes is being driven by multiple global trends, including population ageing, urbanization, economic transition, sedentary lifestyles, and poor dietary habits—such as rising consumption of processed foods, sugar-sweetened beverages, and red meats.
Insulin Deliver Devices Market, By End User
Based on end users, the Insulin delivery devices market is bifurcated into home care settings, hospitals & Clinics, and Other End Users. Among these in 2024, Home care settings segment accounted for the major share in the market and is also expected to grow at the fastest CAGR during the forecast period. This is due to the increasing emphasis on patient-centered care and the growing prevalence of diabetes worldwide. With advancements in technology, insulin delivery devices have become more user-friendly, portable, and easy to operate, enabling patients to manage their condition effectively outside of hospital settings.
REGION
Asia Pacific to be fastest-growing region in global insulin delivery devices market during forecast period
Based on region, the Insulin delivery devices market is bifurcated into North America, Europe, Asia Pacific, Latin America and Middle east & Africa. Among these, during forecast period, Asia Pacific is the fastest-growing regional market for insulin delivery devices. This is due to the rapidly increasing prevalence This sharp demographic shift is creating a substantial demand for effective diabetes management solutions, including insulin delivery devices. of diabetes, particularly in densely populated countries like India and China. This sharp demographic shift is creating a substantial demand for effective diabetes management solutions, including insulin delivery devices.
Insulin Delivery Devices Market: COMPANY EVALUATION MATRIX
The insulin delivery device market is characterized by strong competition among leading global players such as Embecta Corp., Novo Nordisk A/S, Medtronic Plc, Sanofi, and Eli Lilly and Company. Embecta Corp. excels through its broad portfolio of advanced insulin delivery solutions. Novo Nordisk maintains a robust global footprint with innovative insulin pens and needles. Medtronic leverages its diversified product range and strategic growth initiatives, while Sanofi and Eli Lilly continue to strengthen their market positions through innovation-driven insulin pen technologies.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size Value in 2024 | USD 32.63 Billion |
| Revenue Forecast in 2030 | USD 52.65 Billion |
| Growth Rate | CAGR of 8.3% from 2025-2030 |
| Actual data | 2023-2030 |
| Base year | 2024 |
| Forecast period | 2025-2030 |
| Units considered | Value (USD Million), Volume (Million Units) |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered |
|
| Regional Scope | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
WHAT IS IN IT FOR YOU: Insulin Delivery Devices Market REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Company Information | Market Share Analysis, By Region (North America and Europe) & Competitive Leadership Mapping for Established Players in the US | Insights on market share analysis by region |
| Geographic Analysis |
|
Country level demand mapping for new product launches and localization strategy planning. |
RECENT DEVELOPMENTS
- January 2025 : Novo Nordisk A/S launched Awiqli (insulin icodec Injection) in Japan in a prefilled FlexTouch pen.
- December 2024 : Novo Nordisk successfully completed the acquisition of three manufacturing facilities from Novo Holdings A/S. This transaction follows Novo Holdings’ finalization of its acquisition of Catalent, Inc. (Catalent), a leading global contract development and manufacturing organization (CDMO). The integration of these manufacturing sites aligns with Novo Nordisk’s strategic objective of expanding access to its current and future treatments for individuals living with diabetes and obesity.
- November 2024 : Medtronic received USFDA approval for the InPen System, which is a home-use reusable pen for single-patient used by people with diabetes under the supervision of an adult caregiver, or by a patient aged 7 and older for the self-injection of a desired dose of insulin.
- August 2024 : Embecta Corp. announced that it has received 510(k) clearance from the USFDA for its proprietary disposable insulin delivery system. This system features a tubeless patch pump design equipped with a 300-unit insulin reservoir.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
TITLE
PAGE NO
1
INTRODUCTION
33
2
RESEARCH METHODOLOGY
39
3
EXECUTIVE SUMMARY
52
4
PREMIUM INSIGHTS
56
5
MARKET OVERVIEW
Technological innovations and strategic partnerships drive growth in the evolving insulin delivery market.
60
5.1
INTRODUCTION
5.2
MARKET DYNAMICS
5.2.1
DRIVERS
5.2.1.1
GROWTH IN PREVALENCE OF DIABETIC POPULATION
5.2.1.2
TECHNOLOGICAL ADVANCEMENTS IN INSULIN DELIVERY DEVICES
5.2.1.3
GOVERNMENT SUPPORT AND FAVORABLE REIMBURSEMENT SCHEMES TO FAVOR THE MARKET GROWTH
5.2.2
RESTRAINTS
5.2.2.1
HIGH COST AND LACK OF REIMBURSEMENT IN EMERGING ECONOMIES
5.2.2.2
NEEDLE ANXIETY IN PATIENTS TO AFFECT GROWTH OF PEN NEEDLES AND SYRINGES MARKET
5.2.2.3
ORAL INSULIN AS ALTERNATIVE DRUG DELIVERY METHOD
5.2.3
OPPORTUNITIES
5.2.3.1
INCREASE IN RESEARCH & DEVELOPMENT ACTIVITIES AND STRATEGIC PARTNERSHIPS
5.2.3.2
INCREASE IN HEALTHCARE EXPENDITURE ON DIABETES CARE
5.2.3.3
ADVANCES IN INSULIN SYRINGE AND NEEDLE TECHNOLOGY
5.2.3.4
MANDATES PERTAINING TO SAFETY-ENGINEERED MEDICAL NEEDLES
5.2.4
CHALLENGES
5.2.4.1
NEEDLESTICK INJURIES AND MISUSE OF INJECTION PENS
5.2.4.2
LACK OF INTEROPERABILITY AMONG INSULIN DELIVERY DEVICES
5.3
REGULATORY ANALYSIS
5.3.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.3.2
REGULATORY FRAMEWORK
5.3.2.1
NORTH AMERICA
5.3.2.2
EUROPE
5.3.2.3
ASIA PACIFIC
5.3.2.4
LATIN AMERICA
5.3.2.5
MIDDLE EAST
5.3.2.6
AFRICA
5.4
INDUSTRY TRENDS
5.4.1
GROWING DEMAND FOR HYBRID CLOSED-LOOP SYSTEMS/ARTIFICIAL PANCREAS DEVICE SYSTEMS
5.4.2
SYNCHRONIZATION OF SMART INSULIN PENS WITH CONTINUOUS GLUCOSE MONITORING SYSTEMS PROMOTES DIABETES DATA SHARING
5.4.3
INCREASE IN NUMBER OF COLLABORATIONS AMONG STAKEHOLDERS
5.5
REIMBURSEMENT SCENARIO
5.5.1
GLOBAL COVERAGE AND REIMBURSEMENT
5.6
TECHNOLOGY ANALYSIS
5.7
TECHNOLOGY ANALYSIS
5.7.1
KEY TECHNOLOGIES
5.7.1.1
AUTOMATED INSULIN DELIVERY
5.7.2
COMPLEMENTARY TECHNOLOGIES
5.7.2.1
BLUETOOTH
5.7.3
ADJACENT TECHNOLOGIES
5.7.3.1
CONTINUOUS GLUCOSE MONITORING
5.8
KEY CONFERENCES & EVENTS
5.9
PRICING ANALYSIS
5.9.1
INDICATIVE PRICING TREND OF INSULIN DELIVERY DEVICE, BY KEY PLAYER
5.9.2
INDICATIVE PRICING TREND OF INSULIN DELIVERY DEVICE, BY REGION
5.10
TRADE ANALYSIS
5.11
PATENT ANALYSIS
5.11.1
PATENT PUBLICATION TRENDS FOR INSULIN DELIVERY DEVICES
5.11.2
JURISDICTION ANALYSIS: TOP APPLICANTS FOR PATENTS IN INSULIN DELIVERY DEVICES MARKET
5.12
SUPPLY CHAIN ANALYSIS
5.13
VALUE CHAIN ANALYSIS
5.14
ECOSYSTEM MARKET MAP
5.15
CASE STUDY ANALYSIS
5.15.1
OMNIPOD 5 FACILITATED EFFECTIVE INSULIN MANAGEMENT FOR YOUNG ATHLETES, SUPPORTING CONTINUITY IN TRAINING AND COMPETITION
5.15.2
MEDTRONIC MINIMED INSULIN PUMP ENHANCED GLUCOSE CONTROL, IMPROVING DAILY MANAGEMENT FOR PEOPLE WITH DIABETES
5.15.3
SMART INSULIN DELIVERY WITH MEDTRONIC INPEN FOR IMPROVED DIABETES MANAGEMENT
5.16
PORTER’S FIVE FORCES ANALYSIS
5.16.1
INTENSITY OF COMPETITIVE RIVALRY
5.16.2
BARGAINING POWER OF SUPPLIERS
5.16.3
BARGAINING POWER OF BUYERS
5.16.4
THREAT OF SUBSTITUTES
5.16.5
THREAT OF NEW ENTRANTS
5.17
KEY STAKEHOLDERS AND BUYING CRITERIA
5.17.1
KEY STAKEHOLDERS IN BUYING PROCESS
5.17.2
BUYING CRITERIA
5.18
ADJACENT MARKET ANALYSIS
5.19
INVESTMENT & FUNDING SCENARIO
5.20
UNMET NEEDS/END-USER EXPECTATIONS IN INSULIN DELIVERY DEVICES MARKET
5.21
TRENDS/DISRUPTION IMPACTING CUSTOMER’S BUSINESS
5.22
IMPACT OF AI/GENERATIVE AI ON INSULIN DELIVERY DEVICES MARKET
6
INSULIN DELIVERY DEVICES MARKET, BY TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 26 Data Tables
106
6.1
INTRODUCTION
6.2
INSULIN PENS
6.2.1
ADVANCED AND CONVENIENT SOLUTIONS FOR INSULIN ADMINISTRATION TO DRIVE MARKET
6.2.2
REUSABLE INSULIN PENS
6.2.2.1
TECHNOLOGY INNOVATIONS OFFERING COST-EFFECTIVENESS TO BOOST GROWTH
6.2.3
DISPOSABLE INSULIN PENS
6.2.3.1
EASE OF USE TO DRIVE MARKET, THOUGH SHIFT TOWARD ECO-FRIENDLY ENVIRONMENT CAN CHALLENGE GROWTH
6.3
INSULIN PUMPS
6.3.1
PRECISION OFFERED BY NEWER AND MORE REFINED TECHNOLOGY TO DRIVE INSULIN PUMPS MARKET
6.3.2
TETHERED INSULIN PUMPS
6.3.2.1
INCREASE IN COLLABORATIONS AND PARTNERSHIPS BETWEEN COMPANIES TO DEVELOP INTEGRATED CGM SYSTEMS TO DRIVE MARKET
6.3.3
TUBELESS INSULIN PUMPS
6.3.3.1
USE OF ARTIFICIAL INTELLIGENCE AND TECHNOLOGICAL ADVANCEMENTS TO BOOST MARKET
6.4
INSULIN PEN NEEDLES
6.4.1
STANDARD INSULIN PEN NEEDLES
6.4.1.1
AFFORDABILITY OF STANDARD INSULIN PEN NEEDLES OVER SAFETY PEN NEEDLES TO PROPEL GROWTH
6.4.2
SAFETY INSULIN PEN NEEDLES
6.4.2.1
REDUCED CHANCES OF INFECTION AND ACCIDENTAL PRICKING TO DRIVE MARKET
6.5
INSULIN SYRINGES
6.5.1
COMMONLY USED DELIVERY MEANS CHALLENGED BY SAFETY CONCERNS AND AWARENESS OF AFFORDABLE ALTERNATIVES
6.6
OTHER INSULIN DELIVERY DEVICES
7
INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 6 Data Tables
130
7.1
INTRODUCTION
7.2
TYPE 1 DIABETES
7.2.1
CHRONIC NATURE OF TYPE 1 DIABETES, COMBINED WITH SIGNIFICANT INCIDENCE IN CHILDREN AND YOUNG ADULTS, TO DRIVE GROWTH
7.3
TYPE 2 DIABETES
7.3.1
RISING PREVALENCE OF TYPE 2 DIABETES, DRIVEN BY LIFESTYLE-RELATED RISK FACTORS AND EARLIER DISEASE ONSET TO FUEL MARKET
8
INSULIN DELIVERY DEVICES MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 8 Data Tables
137
8.1
INTRODUCTION
8.2
HOME CARE SETTINGS
8.2.1
INCREASE IN AFFORDABILITY OF SELF-MONITORING SYSTEMS AND INSULIN DELIVERY DEVICES TO FUEL SELF/HOME HEALTHCARE
8.3
HOSPITALS & CLINICS
8.3.1
RISE IN DEMAND FOR POINT-OF-CARE TESTING IN HOSPITALS TO BOOST MARKET GROWTH
8.4
OTHER END USERS
9
INSULIN DELIVERY DEVICES MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 14 Countries | 301 Data Tables.
146
9.1
INTRODUCTION
9.2
NORTH AMERICA
9.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
9.2.2
US
9.2.2.1
LARGEST SHARE OF NORTH AMERICAN INSULIN DELIVERY DEVICE MARKET
9.2.3
CANADA
9.2.3.1
RISE IN GOVERNMENT SUPPORT TO BOOST MARKET IN CANADA
9.3
EUROPE
9.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
9.3.2
GERMANY
9.3.2.1
GERMANY TO DOMINATE EUROPEAN INSULIN DELIVERY DEVICES MARKET
9.3.3
UK
9.3.3.1
GOVERNMENT SUPPORT AND RESEARCH FUNDING TO DRIVE MARKET GROWTH IN UK
9.3.4
FRANCE
9.3.4.1
HIGH INSURANCE COVERAGE AND INCREASING AFFORDABILITY TO FUEL MARKET
9.3.5
ITALY
9.3.5.1
INCREASE IN GOVERNMENT SPENDING TO DRIVE INSULIN DELIVERY DEVICE GROWTH IN ITALY
9.3.6
SPAIN
9.3.6.1
MINIMAL CO-PAYMENTS AND FULL REIMBURSEMENT TO DRIVE MARKET GROWTH IN SPAIN
9.3.7
REST OF EUROPE (ROE)
9.4
ASIA PACIFIC
9.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
9.4.2
CHINA
9.4.2.1
CHINA TO DOMINATE ASIA PACIFIC’S INSULIN DELIVERY DEVICES MARKET
9.4.3
JAPAN
9.4.3.1
RISE IN AGING POPULATION AND HIGH DIABETES CASES TO DRIVE GROWTH IN JAPAN
9.4.4
INDIA
9.4.4.1
RISE IN DIABETES CASES AND AFFORDABLE LOCAL MANUFACTURING TO FUEL INSULIN DEVICE DEMAND IN INDIA
9.4.5
AUSTRALIA
9.4.5.1
GOVERNMENT SUBSIDIES TO SUPPORT MARKET GROWTH
9.4.6
SOUTH KOREA
9.4.6.1
RISE IN DIABETES CASES AND STRONG GOVERNMENT HEALTHCARE SUPPORT TO BOOST MARKET
9.4.7
REST OF ASIA PACIFIC
9.5
LATIN AMERICA
9.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
9.5.2
BRAZIL
9.5.2.1
BRAZIL TO ACCOUNT FOR LARGEST SHARE IN LATIN AMERICAN INSULIN DELIVERY DEVICES MARKET
9.5.3
MEXICO
9.5.3.1
GROWTH IN REGULATORY SUPPORT TO PROPEL MARKET
9.5.4
REST OF LATIN AMERICA
9.6
MIDDLE EAST & AFRICA
9.6.1
MACROECONOMIC OUTLOOK FOR THE MIDDLE EAST & AFRICA
9.6.2
GCC COUNTRIES
9.6.2.1
RISE IN DIABETES PREVALENCE AND HIGH PER CAPITA HEALTHCARE EXPENDITURE TO DRIVE MARKET IN GCC COUNTRIES
9.6.3
REST OF THE MIDDLE EAST & AFRICA
10
COMPETITIVE LANDSCAPE
Uncover strategic maneuvers and market dominance of key insulin delivery device players.
262
10.1
INTRODUCTION
10.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
10.2.1
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN INSULIN DELIVERY DEVICES MARKET
10.3
REVENUE ANALYSIS, 2022–2024
10.4
MARKET SHARE ANALYSIS, 2024
10.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
10.5.1
STARS
10.5.2
EMERGING LEADERS
10.5.3
PERVASIVE PLAYERS
10.5.4
PARTICIPANTS
10.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2024
10.5.5.1
COMPANY FOOTPRINT
10.5.5.2
TYPE FOOTPRINT
10.5.5.3
REGION FOOTPRINT
10.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
10.6.1
PROGRESSIVE COMPANIES
10.6.2
RESPONSIVE COMPANIES
10.6.3
DYNAMIC COMPANIES
10.6.4
STARTING BLOCKS
10.6.5
COMPETITIVE BENCHMARKING
10.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES, 2024
10.6.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
10.7
BRAND/PRODUCT COMPARISON
10.8
COMPANY VALUATION & FINANCIAL METRICS
10.8.1
FINANCIAL METRICS
10.8.2
COMPANY VALUATION
10.9
R&D ASSESSMENT OF KEY PLAYERS
10.10
COMPETITIVE SCENARIO
10.10.1
PRODUCT LAUNCHES & APPROVALS
10.10.2
DEALS
10.10.3
EXPANSIONS
10.10.4
OTHER DEVELOPMENTS
11
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
296
11.1
KEY PLAYERS
11.1.1
EMBECTA CORP. (FORMERLY BECTON, DICKINSON AND COMPANY DIABETES CARE BUSINESS)
11.1.1.1
BUSINESS OVERVIEW
11.1.1.2
PRODUCTS OFFERED
11.1.1.3
RECENT DEVELOPMENTS
11.1.1.4
MNM VIEW
11.1.2
NOVO NORDISK A/S
11.1.3
MEDTRONIC
11.1.4
SANOFI
11.1.5
ELI LILLY AND COMPANY
11.1.6
TANDEM DIABETES CARE, INC.
11.1.7
INSULET CORPORATION
11.1.8
BIOCON
11.1.9
ROCHE DIABETES CARE
11.1.10
HTL-STREFA (SUBSIDIARY OF THE MTD GROUP)
11.1.11
YPSOMED
11.1.12
MEDTRUM TECHNOLOGIES INC.
11.1.13
TERUMO CORPORATION
11.1.14
WOCKHARDT LIMITED
11.1.15
NIPRO
11.2
OTHER PLAYERS
11.2.1
CEQUR CORPORATION
11.2.2
EOFLOW CO., LTD.
11.2.3
HINDUSTAN SYRINGES & MEDICAL DEVICES LTD
11.2.4
SOOIL DEVELOPMENTS CO., LTD
11.2.5
SUNGSHIM MEDICAL CO., LTD.
11.2.6
B.BRAUN SE
11.2.7
DEBIOTECH SA
11.2.8
JIANGSU DELFU MEDICAL DEVICE CO., LTD
11.2.9
HASELMEIER (A SUBSIDIARY OF MEDMIX)
11.2.10
MANNKIND CORPORATION
12
APPENDIX
370
12.1
DISCUSSION GUIDE
12.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3
CUSTOMIZATION OPTIONS
12.4
RELATED REPORTS
12.5
AUTHOR DETAILS
LIST OF TABLES
TABLE 1
INCLUSION AND EXCLUSIONS
TABLE 2
STANDARD CURRENCY CONVERSION RATES (USD)
TABLE 3
RISK ASSESSMENT: INSULIN DELIVERY DEVICES MARKET
TABLE 4
TOP 10 COUNTRIES/TERRITORIES WITH HIGHEST NUMBER OF ADULTS (20–79 YEARS) WITH DIABETES, 2024 AND 2050 (MILLION)
TABLE 5
TOTAL DIABETES-RELATED HEALTH EXPENDITURE ACROSS REGIONS, 2024 AND 2050 (USD MILLION)
TABLE 6
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10
MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11
US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
TABLE 12
EUROPE: MEDICAL DEVICES, BY CLASS
TABLE 13
EUROPE: CONFORMITY ASSESSMENT
TABLE 14
JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODY
TABLE 15
CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
TABLE 16
INDIA: MEDICAL DEVICE CLASSIFICATION
TABLE 17
HYBRID CLOSED-LOOP SYSTEMS: CURRENT MARKET SCENARIO
TABLE 18
MAJOR SMART INSULIN PENS AVAILABLE GLOBALLY
TABLE 19
RECENT COLLABORATIONS IN INSULIN DELIVERY DEVICE MARKET
TABLE 20
US: INSULIN DELIVERY DEVICE COVERAGE AND REIMBURSEMENT
TABLE 21
CANADA: INSULIN DELIVERY DEVICE COVERAGE AND REIMBURSEMENT
TABLE 22
UK: INSULIN DELIVERY DEVICE COVERAGE AND REIMBURSEMENT
TABLE 23
AUSTRALIA: INSULIN DELIVERY DEVICES COVERAGE AND REIMBURSEMENT
TABLE 24
OTHER COUNTRIES: INSULIN DELIVERY DEVICE COVERAGE AND REIMBURSEMENT
TABLE 25
INSULIN DELIVERY DEVICES MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2025–2026
TABLE 26
INDICATIVE PRICING TREND OF INSULIN DELIVERY DEVICE, BY KEY PLAYER, 2022–2024 (USD)
TABLE 27
INDICATIVE PRICING TREND OF INSULIN DELIVERY DEVICE, BY REGION, 2022–2024 (USD)
TABLE 28
IMPORT DATA FOR INSULIN DELIVERY SYSTEMS (HS CODE: 901839), BY COUNTRY, 2020–2023 (USD THOUSAND)
TABLE 29
EXPORT DATA FOR INSULIN DELIVERY SYSTEMS (HS CODE: 901839), BY COUNTRY, 2020–2023 (USD THOUSAND)
TABLE 30
LIST OF PATENTS IN INSULIN DELIVERY DEVICES MARKET, 2022−2024
TABLE 31
INSULIN DELIVERY DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 32
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF END USERS
TABLE 33
KEY BUYING CRITERIA FOR END USERS
TABLE 34
UNMET NEEDS: INSULIN DELIVERY DEVICES MARKET
TABLE 35
END-USER EXPECTATIONS: INSULIN DELIVERY DEVICES MARKET
TABLE 36
INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION)
TABLE 37
INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 38
INSULIN PENS MARKET, BY TYPE, 2022–2024 (USD MILLION)
TABLE 39
INSULIN PENS MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 40
REUSABLE INSULIN PENS MARKET, BY COUNTRY, 2022–2024 (USD MILLION)
TABLE 41
REUSABLE INSULIN PENS MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 42
DISPOSABLE INSULIN PENS MARKET, BY COUNTRY, 2022–2024 (USD MILLION)
TABLE 43
DISPOSABLE INSULIN PENS MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 44
INSULIN PUMPS MARKET, BY TYPE, 2022–2024 (USD MILLION)
TABLE 45
INSULIN PUMPS MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 46
TETHERED INSULIN PUMPS MARKET, BY COUNTRY, 2022–2024 (USD MILLION)
TABLE 47
TETHERED INSULIN PUMPS MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 48
TUBELESS INSULIN PUMPS MARKET, BY COUNTRY, 2022–2024 (USD MILLION)
TABLE 49
TUBELESS INSULIN PUMPS MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 50
INSULIN PEN NEEDLES MARKET, BY TYPE, 2022–2024 (USD MILLION)
TABLE 51
INSULIN PEN NEEDLES MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 52
STANDARD INSULIN PEN NEEDLES OFFERED BY KEY PLAYERS
TABLE 53
STANDARD INSULIN PEN NEEDLES MARKET, BY COUNTRY, 2022–2024 (USD MILLION)
TABLE 54
STANDARD INSULIN PEN NEEDLES MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 55
SAFETY INSULIN PEN NEEDLES OFFERED BY KEY PLAYERS
TABLE 56
SAFETY INSULIN PEN NEEDLES MARKET, BY COUNTRY, 2022–2024 (USD MILLION)
TABLE 57
SAFETY INSULIN PEN NEEDLES MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 58
INSULIN SYRINGES MARKET, BY COUNTRY, 2022–2024 (USD MILLION)
TABLE 59
INSULIN SYRINGES MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 60
OTHER INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2022–2024 (USD MILLION)
TABLE 61
OTHER INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 62
INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION)
TABLE 63
INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION)
TABLE 64
INSULIN DELIVERY DEVICES MARKET FOR TYPE 1 DIABETES, BY COUNTRY, 2022–2024 (USD MILLION)
TABLE 65
INSULIN DELIVERY DEVICES MARKET FOR TYPE 1 DIABETES, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 66
INSULIN DELIVERY DEVICES MARKET FOR TYPE 2 DIABETES, BY COUNTRY, 2022–2024 (USD MILLION)
TABLE 67
INSULIN DELIVERY DEVICES MARKET FOR TYPE 2 DIABETES, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 68
INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION)
TABLE 69
INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION)
TABLE 70
INSULIN DELIVERY DEVICES MARKET FOR HOME CARE SETTINGS, BY REGION, 2022–2024 (USD MILLION)
TABLE 71
INSULIN DELIVERY DEVICES MARKET FOR HOME CARE SETTINGS, BY REGION, 2025–2030 (USD MILLION)
TABLE 72
INSULIN DELIVERY DEVICES MARKET FOR HOSPITALS & CLINICS, BY REGION, 2022–2024 (USD MILLION)
TABLE 73
INSULIN DELIVERY DEVICES MARKET FOR HOSPITALS & CLINICS, BY REGION, 2025–2030 (USD MILLION)
TABLE 74
INSULIN DELIVERY DEVICES MARKET FOR OTHER END USERS, BY REGION, 2022–2024 (USD MILLION)
TABLE 75
INSULIN DELIVERY DEVICES MARKET FOR OTHER END USERS, BY REGION, 2025–2030 (USD MILLION)
TABLE 76
INSULIN DELIVERY DEVICES MARKET, BY REGION, 2022–2024 (USD MILLION)
TABLE 77
INSULIN DELIVERY DEVICES MARKET, BY REGION, 2025–2030 (USD MILLION)
TABLE 78
NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2022–2024 (USD MILLION)
TABLE 79
NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 80
NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION)
TABLE 81
NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 82
NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 83
NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 84
NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 85
NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 86
NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION)
TABLE 87
NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION)
TABLE 88
NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION)
TABLE 89
NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION)
TABLE 90
NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION)
TABLE 91
NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION)
TABLE 92
US: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION)
TABLE 93
US: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 94
US: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 95
US: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 96
US: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 97
US: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 98
US: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION)
TABLE 99
US: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION)
TABLE 100
US: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION)
TABLE 101
US: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION)
TABLE 102
US: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION)
TABLE 103
US: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION)
TABLE 104
ELIGIBILITY FOR INSULIN PUMPS AND SUPPLIES IN CANADA FOR TYPE I DIABETES, 2023
TABLE 105
CANADA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION)
TABLE 106
CANADA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 107
CANADA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 108
CANADA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 109
CANADA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 110
CANADA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 111
CANADA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION)
TABLE 112
CANADA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION)
TABLE 113
CANADA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION)
TABLE 114
CANADA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION)
TABLE 115
CANADA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION)
TABLE 116
CANADA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION)
TABLE 117
EUROPE: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2022–2024 (USD MILLION)
TABLE 118
EUROPE: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 119
EUROPE: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION)
TABLE 120
EUROPE: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 121
EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 122
EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 123
EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 124
EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 125
EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION)
TABLE 126
EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION)
TABLE 127
EUROPE: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION)
TABLE 128
EUROPE: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION)
TABLE 129
EUROPE: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION)
TABLE 130
EUROPE: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION)
TABLE 131
GERMANY: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION)
TABLE 132
GERMANY: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 133
GERMANY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 134
GERMANY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 135
GERMANY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 136
GERMANY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 137
GERMANY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION)
TABLE 138
GERMANY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION)
TABLE 139
GERMANY: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION)
TABLE 140
GERMANY: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION)
TABLE 141
GERMANY: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION)
TABLE 142
GERMANY: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION)
TABLE 143
UK: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION)
TABLE 144
UK: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 145
UK: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 146
UK: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 147
UK: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 148
UK: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 149
UK: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION)
TABLE 150
UK: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION)
TABLE 151
UK: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION)
TABLE 152
UK: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION)
TABLE 153
UK: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION)
TABLE 154
UK: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION)
TABLE 155
FRANCE: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION)
TABLE 156
FRANCE: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 157
FRANCE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 158
FRANCE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 159
FRANCE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 160
FRANCE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 161
FRANCE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION)
TABLE 162
FRANCE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION)
TABLE 163
FRANCE: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION)
TABLE 164
FRANCE: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION)
TABLE 165
FRANCE: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION)
TABLE 166
FRANCE: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION)
TABLE 167
ITALY: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION)
TABLE 168
ITALY: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 169
ITALY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 170
ITALY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 171
ITALY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 172
ITALY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 173
ITALY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION)
TABLE 174
ITALY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION)
TABLE 175
ITALY: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION)
TABLE 176
ITALY: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION)
TABLE 177
ITALY: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION)
TABLE 178
ITALY: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION)
TABLE 179
SPAIN: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION)
TABLE 180
SPAIN: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 181
SPAIN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 182
SPAIN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 183
SPAIN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 184
SPAIN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 185
SPAIN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION)
TABLE 186
SPAIN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION)
TABLE 187
SPAIN: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION)
TABLE 188
SPAIN: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION)
TABLE 189
SPAIN: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION)
TABLE 190
SPAIN: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION)
TABLE 191
REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION)
TABLE 192
REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 193
REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 194
REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 195
REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 196
REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 197
REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION)
TABLE 198
REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION)
TABLE 199
REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION)
TABLE 200
REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION)
TABLE 201
REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION)
TABLE 202
REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION)
TABLE 203
ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2022–2024 (USD MILLION)
TABLE 204
ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 205
ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION)
TABLE 206
ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 207
ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 208
ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 209
ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 210
ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 211
ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION)
TABLE 212
ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION)
TABLE 213
ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION)
TABLE 214
ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION)
TABLE 215
ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION)
TABLE 216
ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION)
TABLE 217
CHINA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION)
TABLE 218
CHINA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 219
CHINA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 220
CHINA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 221
CHINA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 222
CHINA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 223
CHINA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION)
TABLE 224
CHINA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION)
TABLE 225
CHINA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION)
TABLE 226
CHINA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION)
TABLE 227
CHINA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION)
TABLE 228
CHINA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION)
TABLE 229
JAPAN: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION)
TABLE 230
JAPAN: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 231
JAPAN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 232
JAPAN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 233
JAPAN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 234
JAPAN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 235
JAPAN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION)
TABLE 236
JAPAN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION)
TABLE 237
JAPAN: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION)
TABLE 238
JAPAN: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION)
TABLE 239
JAPAN: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION)
TABLE 240
JAPAN: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION)
TABLE 241
INDIA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION)
TABLE 242
INDIA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 243
INDIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 244
INDIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 245
INDIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 246
INDIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 247
INDIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION)
TABLE 248
INDIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION)
TABLE 249
INDIA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION)
TABLE 250
INDIA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION)
TABLE 251
INDIA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION)
TABLE 252
INDIA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION)
TABLE 253
AUSTRALIA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION)
TABLE 254
AUSTRALIA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 255
AUSTRALIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 256
AUSTRALIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 257
AUSTRALIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 258
AUSTRALIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 259
AUSTRALIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION)
TABLE 260
AUSTRALIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION)
TABLE 261
AUSTRALIA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION)
TABLE 262
AUSTRALIA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION)
TABLE 263
AUSTRALIA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION)
TABLE 264
AUSTRALIA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION)
TABLE 265
SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION)
TABLE 266
SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 267
SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 268
SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 269
SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 270
SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 271
SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION)
TABLE 272
SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION)
TABLE 273
SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION)
TABLE 274
SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION)
TABLE 275
SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION)
TABLE 276
SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION)
TABLE 277
REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION)
TABLE 278
REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 279
REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 280
REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 281
REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 282
REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 283
REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION)
TABLE 284
REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION)
TABLE 285
REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION)
TABLE 286
REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION)
TABLE 287
REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION)
TABLE 288
REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION)
TABLE 289
LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2022–2024 (USD MILLION)
TABLE 290
LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 291
LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION)
TABLE 292
LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 293
LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 294
LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 295
LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 296
LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 297
LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION)
TABLE 298
LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION)
TABLE 299
LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION)
TABLE 300
LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION)
TABLE 301
LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION)
TABLE 302
LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION)
TABLE 303
BRAZIL: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION)
TABLE 304
BRAZIL: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 305
BRAZIL: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 306
BRAZIL: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 307
BRAZIL: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 308
BRAZIL: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 309
BRAZIL: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION)
TABLE 310
BRAZIL: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION)
TABLE 311
BRAZIL: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION)
TABLE 312
BRAZIL: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION)
TABLE 313
BRAZIL: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION)
TABLE 314
BRAZIL: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION)
TABLE 315
MEXICO: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION)
TABLE 316
MEXICO: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 317
MEXICO: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 318
MEXICO: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 319
MEXICO: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 320
MEXICO: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 321
MEXICO: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION)
TABLE 322
MEXICO: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION)
TABLE 323
MEXICO: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION)
TABLE 324
MEXICO: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION)
TABLE 325
MEXICO: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION)
TABLE 326
MEXICO: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION)
TABLE 327
REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION)
TABLE 328
REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 329
REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 330
REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 331
REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 332
REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 333
REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION)
TABLE 334
REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION)
TABLE 335
REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION)
TABLE 336
REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION)
TABLE 337
REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION)
TABLE 338
REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION)
TABLE 339
MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2022–2024 (USD MILLION)
TABLE 340
MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 341
MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION)
TABLE 342
MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 343
MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 344
MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 345
MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 346
MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 347
MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION)
TABLE 348
MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION)
TABLE 349
MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION)
TABLE 350
MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION)
TABLE 351
MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION)
TABLE 352
MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION)
TABLE 353
GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION)
TABLE 354
GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 355
GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 356
GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 357
GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 358
GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 359
GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION)
TABLE 360
GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION)
TABLE 361
GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION)
TABLE 362
GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION)
TABLE 363
GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION)
TABLE 364
GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION)
TABLE 365
REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION)
TABLE 366
REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 367
REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 368
REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 369
REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION)
TABLE 370
REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION)
TABLE 371
REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION)
TABLE 372
REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION)
TABLE 373
REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION)
TABLE 374
REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION)
TABLE 375
REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION)
TABLE 376
REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION)
TABLE 377
OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN INSULIN DELIVERY DEVICES MARKET
TABLE 378
INSULIN DELIVERY DEVICE MARKET: DEGREE OF COMPETITION
TABLE 379
INSULIN DELIVERY DEVICES MARKET: TYPE FOOTPRINT, 2024
TABLE 380
INSULIN DELIVERY DEVICES MARKET: REGION FOOTPRINT, 2024
TABLE 381
INSULIN DELIVERY DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2024
TABLE 382
INSULIN DELIVERY DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, 2024
TABLE 383
INSULIN DELIVERY DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–APRIL 2025
TABLE 384
INSULIN DELIVERY DEVICES MARKET: DEALS, JANUARY 2022–APRIL 2025
TABLE 385
INSULIN DELIVERY DEVICES MARKET: EXPANSIONS, JANUARY 2022–APRIL 2025
TABLE 386
INSULIN DELIVERY DEVICES MARKET: OTHER DEVELOPMENTS, JANUARY 2022–APRIL 2025
TABLE 387
EMBECTA CORP.: BUSINESS OVERVIEW
TABLE 388
EMBECTA CORP.: PRODUCTS OFFERED
TABLE 389
EMBECTA CORP: PRODUCTS LAUNCHES & APPROVALS
TABLE 390
EMBECTA CORP: DEALS
TABLE 391
EMBECTA CORP: EXPANSIONS
TABLE 392
EMBECTA CORP.: OTHER DEVELOPMENTS
TABLE 393
NOVO NORDISK A/S: BUSINESS OVERVIEW
TABLE 394
NOVO NORDISK A/S: PRODUCTS OFFERED
TABLE 395
NOVO NORDISK A/S: PRODUCTS LAUNCHES & APPROVALS
TABLE 396
NOVO NORDISK A/S: DEALS
TABLE 397
NOVO NORDISK A/S: OTHER DEVELOPMENTS
TABLE 398
MEDTRONIC: BUSINESS OVERVIEW
TABLE 399
MEDTRONIC: PRODUCTS OFFERED
TABLE 400
MEDTRONIC: PRODUCT LAUNCHES & APPROVALS
TABLE 401
MEDTRONIC: DEALS
TABLE 402
MEDTRONIC: EXPANSIONS
TABLE 403
MEDTRONIC: OTHER DEVELOPMENTS
TABLE 404
SANOFI: BUSINESS OVERVIEW
TABLE 405
SANOFI: PRODUCTS OFFERED
TABLE 406
SANOFI: PRODUCT LAUNCHES & APPROVALS
TABLE 407
SANOFI: EXPANSIONS
TABLE 408
SANOFI: OTHER DEVELOPMENTS
TABLE 409
ELI LILLY AND COMPANY: BUSINESS OVERVIEW
TABLE 410
ELI LILLY AND COMPANY: PRODUCTS OFFERED
TABLE 411
ELI LILLY AND COMPANY: PRODUCTS LAUNCHES
TABLE 412
ELI LILLY AND COMPANY: DEALS
TABLE 413
ELI LILLY AND COMPANY: EXPANSIONS
TABLE 414
ELI LILLY AND COMPANY: OTHER DEVELOPMENTS
TABLE 415
TANDEM DIABETES CARE, INC.: BUSINESS OVERVIEW
TABLE 416
TANDEM DIABETES CARE, INC.: PRODUCTS OFFERED
TABLE 417
TANDEM DIABETES CARE, INC.: PRODUCTS LAUNCHES & APPROVALS
TABLE 418
TANDEM DIABETES CARE, INC.: DEALS
TABLE 419
INSULET CORPORATION: BUSINESS OVERVIEW
TABLE 420
INSULET CORPORATION: PRODUCTS LAUNCHES & APPROVALS
TABLE 421
INSULET CORPORATION: DEALS
TABLE 422
INSULET CORPORATION: EXPANSIONS
TABLE 423
INSULET CORPORATION: OTHER DEVELOPMENTS
TABLE 424
BIOCON: BUSINESS OVERVIEW
TABLE 425
BIOCON: PRODUCTS OFFERED
TABLE 426
BIOCON: DEALS
TABLE 427
BIOCON: OTHER DEVELOPMENTS
TABLE 428
F. HOFFMANN-LA ROCHE: BUSINESS OVERVIEW
TABLE 429
F. HOFFMANN-LA ROCHE: PRODUCTS OFFERED
TABLE 430
HOFFMANN-LA ROCHE LTD.: PRODUCTS LAUNCHES
TABLE 431
HTL-STREFA (SUBSIDIARY OF THE MTD GROUP): BUSINESS OVERVIEW
TABLE 432
HTL-STREFA (SUBSIDIARY OF THE MTD GROUP): PRODUCTS OFFERED
TABLE 433
HTL-STREFA (SUBSIDIARY OF THE MTD GROUP): DEALS
TABLE 434
YPSOMED: BUSINESS OVERVIEW
TABLE 435
YPSOMED: PRODUCTS OFFERED
TABLE 436
YPSOMED: PRODUCT LAUNCHES & APPROVALS
TABLE 437
YPSOMED: DEALS
TABLE 438
YPSOMED: EXPANSIONS
TABLE 439
YPSOMED: OTHER DEVELOPMENTS
TABLE 440
MEDTRUM TECHNOLOGIES INC.: BUSINESS OVERVIEW
TABLE 441
MEDTRUM TECHNOLOGIES INC.: PRODUCT PORTFOLIO
TABLE 442
TERUMO CORPORATION: BUSINESS OVERVIEW
TABLE 443
TERUMO CORPORATION: PRODUCTS OFFERED
TABLE 444
TERUMO CORPORATION: PRODUCT LAUNCHES
TABLE 445
TERUMO CORPORATION: DEALS
TABLE 446
TERUMO CORPORATION: EXPANSIONS
TABLE 447
TERUMO CORPORATION: OTHER DEVELOPMENTS
TABLE 448
WOCKHARDT LIMITED: BUSINESS OVERVIEW
TABLE 449
WOCKHARDT LIMITED: PRODUCTS OFFERED
TABLE 450
WOCKHARDT LIMITED: PRODUCTS LAUNCHES
TABLE 451
WOCKHARDT LIMITED: OTHER DEVELOPMENTS
TABLE 452
NIPRO: BUSINESS OVERVIEW
TABLE 453
NIPRO: PRODUCTS OFFERED
TABLE 454
NIPRO: EXPANSIONS
LIST OF FIGURES
FIGURE 1
INSULIN DELIVERY DEVICES MARKET SEGMENTATION
FIGURE 2
STUDY YEARS CONSIDERED
FIGURE 3
RESEARCH DESIGN
FIGURE 4
KEY DATA FROM SECONDARY SOURCES
FIGURE 5
PRIMARY SOURCES
FIGURE 6
KEY DATA FROM PRIMARY SOURCES
FIGURE 7
KEY INDUSTRY INSIGHTS
FIGURE 8
BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 9
BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 10
MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
FIGURE 11
TOP-DOWN APPROACH
FIGURE 12
INSULIN DELIVERY DEVICES MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2025–2030)
FIGURE 13
CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
FIGURE 14
DATA TRIANGULATION METHODOLOGY
FIGURE 15
INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 16
INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 17
INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 18
GEOGRAPHICAL SNAPSHOT OF INSULIN DELIVERY DEVICES MARKET
FIGURE 19
INCREASING TECHNOLOGICAL ADVANCEMENTS IN INSULIN DELIVERY DEVICES TO DRIVE MARKET
FIGURE 20
NORTH AMERICA ACCOUNTED FOR LARGEST SHARE OF INSULIN DELIVERY DEVICES MARKET IN 2024
FIGURE 21
CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 22
ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD (2025–2030)
FIGURE 23
DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
FIGURE 24
INSULIN DELIVERY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 25
ESTIMATES OF GLOBAL PREVALENCE OF DIABETES IN 20–79-YEAR AGE GROUP, 2011–2024 (MILLION)
FIGURE 26
DIABETES AGE-STANDARDIZED PREVALENCE IN PEOPLE (65–99 YEARS), BY REGION, 2024 AND 2050 (MILLION)
FIGURE 27
ADVANCEMENTS IN INSULIN DELIVERY DEVICES
FIGURE 28
FDA 510(K) APPROVAL PROCESS
FIGURE 29
EUROPE: CE MARK APPROVAL PROCESS FOR INSULIN DELIVERY DEVICES
FIGURE 30
SUMMARY OF APPROVAL, ACCESS, AND DISTRIBUTION PATHWAYS FOR NEW TECHNOLOGY USED FOR INSULIN DRUG DELIVERY DEVICES
FIGURE 31
TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR INSULIN DELIVERY DEVICES MARKET, JANUARY 2014–DECEMBER 2024
FIGURE 32
TOP PATENT APPLICANT COUNTRIES FOR INSULIN DELIVERY DEVICES, JANUARY 2014–DECEMBER 2024
FIGURE 33
INSULIN DELIVERY DEVICE MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 34
INSULIN DELIVERY DEVICE: VALUE CHAIN ANALYSIS
FIGURE 35
INSULIN DELIVERY DEVICE MARKET: ECOSYSTEM MAPPING
FIGURE 36
INSULIN DELIVERY DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 37
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF END USERS
FIGURE 38
KEY BUYING CRITERIA FOR END USERS
FIGURE 39
INSULIN DELIVERY DEVICES MARKET: ADJACENT MARKET ANALYSIS
FIGURE 40
INVESTMENT/VENTURE CAPITAL SCENARIO IN INSULIN DELIVERY DEVICES, 2021–2023 (USD MILLION)
FIGURE 41
INSULIN DELIVERY DEVICES MARKET: GEOGRAPHIC SNAPSHOT
FIGURE 42
NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET SNAPSHOT
FIGURE 43
ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET SNAPSHOT
FIGURE 44
REVENUE SHARE ANALYSIS OF KEY PLAYERS, 2022–2024 (USD MILLION)
FIGURE 45
MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024
FIGURE 46
INSULIN DELIVERY DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 47
INSULIN DELIVERY DEVICES MARKET: COMPANY FOOTPRINT, 2024
FIGURE 48
INSULIN DELIVERY DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 49
INSULIN DELIVERY DEVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 50
EV/EBITDA OF KEY VENDORS, 2024
FIGURE 51
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2024
FIGURE 52
R&D ASSESSMENT OF KEY PLAYERS
FIGURE 53
EMBECTA CORP.: COMPANY SNAPSHOT, 2024
FIGURE 54
NOVO NORDISK A/S: COMPANY SNAPSHOT, 2024
FIGURE 55
MEDTRONIC: COMPANY SNAPSHOT, 2024
FIGURE 56
SANOFI: COMPANY SNAPSHOT, 2024
FIGURE 57
ELI LILLY AND COMPANY: COMPANY SNAPSHOT, 2024
FIGURE 58
TANDEM DIABETES CARE, INC.: COMPANY SNAPSHOT, 2024
FIGURE 59
INSULET CORPORATION: COMPANY SNAPSHOT, 2024
FIGURE 60
BIOCON: COMPANY SNAPSHOT, 2024
FIGURE 61
F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT, 2024
FIGURE 62
YPSOMED: COMPANY SNAPSHOT, 2024
FIGURE 63
TERUMO CORPORATION: COMPANY SNAPSHOT, 2024
FIGURE 64
WOCKHARDT LIMITED: COMPANY SNAPSHOT, 2024
FIGURE 65
NIPRO: COMPANY SNAPSHOT, 2024
Methodology
The study focused on estimating the current market size of the insulin delivery devices sector. Comprehensive secondary research was conducted to gather information about the industry. The next step involved validating these findings, assumptions, and estimates by consulting industry experts throughout the value chain through primary research. Various methods were used to calculate the total market size, including top-down and bottom-up approaches. Subsequently, market segmentation and data triangulation procedures were employed to determine the size of the segments and subsegments within the insulin delivery devices market.
Secondary Research
The secondary research process involves utilizing a range of secondary sources, including directories and databases such as Bloomberg Business, Factiva, and D&B Hoovers. It also encompasses white papers, annual reports, investor presentations, SEC filings from companies, and publications from various government sources. Notable organizations referenced include the National Institutes of Health (NIH), the US Food and Drug Administration (FDA), the US Census Bureau, the World Health Organization (WHO), the International Trade Administration (ITA), the Global Burden of Disease Study, and the Centers for Medicare and Medicaid Services (CMS).
These resources were used to gather information for the global insulin delivery devices market study. They provided crucial insights into key players within the market, as well as market classification and segmentation based on industry trends. Additionally, important developments related to market and technology perspectives were identified. A database of key industry leaders was also compiled using the information obtained through secondary research.
Primary Research
In the primary research process, interviews were conducted with various sources from both the supply and demand sides to gather qualitative and quantitative information for this report. The supply-side primary sources included industry experts, such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and other key executives from important companies and organizations in the insulin delivery devices market. On the demand side, the primary sources included personnel from home care settings, hospitals, clinics, and other end users. This primary research was carried out to validate market segmentation, identify key players in the market, and gather insights on essential industry trends and dynamics.
A breakdown of the primary respondents is provided below:
Note 1: C-level executives include CEOs, CFOs, COOs, and VPs.
Note 2: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10 billion, Tier 2 = USD 1 billion to USD 10 billion, and Tier 3 = < USD 1 billion.
Source: MarketsandMarkets Analysis
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs (original equipment manufacturers) operating in the global insulin delivery devices market to determine the global market value. All significant product manufacturers were identified at both the global and country/regional levels. Revenue mapping for these key players was conducted for the relevant business segments and subsegments. Additionally, the global insulin delivery devices market was divided into various segments and subsegments based on specific criteria:
- List of major players operating in the products market at the regional and/or country level
- Product mapping of various insulin delivery device manufacturers at the regional and/or country level
- Mapping of annual revenues generated by listed major players from insulin delivery devices (or the nearest reported business unit/product category)
- Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
- Summation of the market value of all segments/subsegments to arrive at the global insulin delivery devices market
The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.
Market Size Estimation (Bottom-up Approach & Top-down Approach)
Data Triangulation
After arriving at the overall size of the global insulin delivery devices market through the above-mentioned methodology, this market was split into several segments and subsegments. Where applicable, the data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macroindicators and regional trends from both demand- and supply-side participants.
Market Definition
Insulin delivery devices are medical devices designed to administer insulin, a hormone used in the management of diabetes, into the body. These devices are primarily used by individuals with diabetes who require insulin therapy to regulate their blood sugar levels. Insulin pens, pumps, pen needles, and syringes are the most widely used delivery devices.
Stakeholders
- Manufacturing companies of insulin pen needles, insulin pens, insulin pumps, insulin syringes, injectable insulin delivery devices, and diabetes supplies
- Suppliers and distributors of insulin pen needles, insulin pens, insulin pumps, insulin syringes, injectable insulin delivery devices, and diabetes supplies
- Pharmaceutical and biopharmaceutical companies
- Healthcare service providers
- Teaching hospitals and academic medical centers
- Health insurance players
- Government bodies/municipal corporations
- Regulatory bodies
- Medical research institutes
- Business research and consulting service providers
- Venture capitalists
- Market research and consulting firms
Report Objectives
- To describe, analyze, and forecast the global insulin delivery devices market on the basis of type, end user, and region
- To describe and forecast the insulin delivery devices market for key regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To provide detailed information regarding the drivers, restraints, opportunities, and challenges influencing the growth of the insulin delivery devices market
- To strategically analyze the ecosystem, regulations, patenting trend, value chain, Porter’s five forces, and prices pertaining to the market under study
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
- To profile the key players and comprehensively analyze their market shares and core competencies in the insulin delivery devices market
- To analyze competitive developments such as partnerships, collaborations, acquisitions, product launches, expansions, and R&D activities in the insulin delivery devices market
- To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product strategy
Frequently Asked Questions (FAQ)
Which are the top industry players in the global insulin delivery devices market?
Embecta Corp. (US), Novo Nordisk A/S (Denmark), Ypsomed (Switzerland), Medtronic, Plc (Ireland), Tandem Diabetes Care, Inc. (US), Sanofi (France), Eli Lilly and Company (US), and Insulet Corporation (US).
What are some of the major drivers for this market?
Growing prevalence of diabetes, technological advancements in insulin delivery devices, and government support and favorable reimbursement schemes.
Which end users have been included in the global insulin delivery devices market?
Hospitals & Clinics, Home Care Settings, and Other End Users.
Which product segments hold the largest market share in the insulin delivery devices market?
The insulin pens segment holds the largest market share.
Which region is the most lucrative in the insulin delivery devices market?
The Asia Pacific market is expected to witness the highest CAGR.
Personalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Insulin Delivery Device Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free Customisation
Before You Go
Expand Beyond Insulin Delivery Device Market
Explore the top 20 industries influencing your market growth
Human and AI Powered Market Intelligence
Find Untapped Markets
Growth opportunities and latent adjacency in Insulin Delivery Device Market